Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Allakos Inc ALLK

Healthcare Biotechnology
Allakos Inc. is a clinical-stage biotechnology company, which is engaged in the development of therapeutics that target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases. The Company’s most advanced product candidate, AK006, is in a Phase I clinical trial. AK006 targets Siglec-6, an inhibitory receptor expressed selectively... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ALLK)

Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire November 6, 2024

Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers

GlobeNewswire October 10, 2024

Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire August 7, 2024

The Schall Law Firm Begins Probe Into Claims Against Allakos Inc And Urges Affected Investors To Participate

Accesswire June 28, 2024

The Schall Law Firm Initiates Investigation Into Allegations Against Allakos Inc And Encourages Impacted Investors To Engage

Accesswire June 26, 2024

Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile

GlobeNewswire June 25, 2024

The Schall Law Firm Begins Probe Into Claims Against Allakos Inc And Urges Affected Investors To Participate

Accesswire June 25, 2024

The Schall Law Firm Initiates Investigation Into Allegations Against Allakos Inc And Encourages Impacted Investors To Join

Accesswire June 24, 2024

The Schall Law Firm Starts Probe Into Claims Against Allakos Inc And Urges Affected Investors To Participate

Accesswire June 23, 2024
View More News ››

Opinion & Analysis (NDAQ:ALLK)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ALLK)

Allakos Presents Preclinical Data Highlighting Inhibition of

News; $ALLK Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024@...
whytestocks - February 26, 2024

SHOULD ALLAKOS INC BE ON YOUR INVESTMENT WATCHLIST?

$ALLK  Allakos Inc. (NASDAQ:ALLK), a clinical-stage biopharmaceutical company developing therapeutic monoclonal antibodies for...
AviseAnalytics - January 10, 2022
View more Bullboard ››

Taranis Resources Inc.

Taranis Resources Inc.

Taranis Resources Inc. is a mineral exploration company. The Company is principally engaged in the acquisition, exploration ...
View More »